Structural valve deterioration in the Mitroflow biological heart valve prosthesis

Early Structural Valve Deterioration of Mitroflow Aortic Bioprosthesis

Early Structural Valve Deterioration of the Mitroflow Aortic Bioprosthesis: Will the New Anticalcification Treatment Change Anything?

T here has been a trend toward more frequent use of biopros-thetic valves, especially in the young generations, over the last decade. 1 Freedom from warfa-rin use and restrictions on diet and activities make bioprosthetic valves more attractive and popular, and multiple reports have shown that choosing a bioprosthetic valve does not decrease survival despite the increased rate of reoperation. T...

Early Structural Valve Deterioration of Mitroflow Aortic Bioprosthesis: Mode, Incidence and Impact on Outcome in a Large Cohort of Patients

Dept of Thoracic and CardioVascular Surgery, University Hospital, Nantes, France; Institut du Thorax, University Hospital, Nantes, France; Member of Translink European Network (dedicated to structural valve deterioration); Dept of Cardiology, University Hospital, Nantes, France; Inserm UMR1087, Nantes, France; Dept of Statistic-EA 4275, University of Medicine, Nantes, France; Dept of Radiology ...

Structural valve deterioration of a Corevalve prosthesis 9 months after implantation.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . doi:10.1093/eurheartj/ehs422 Online publish-ahead-o...

Valvular Heart Disease Prosthesis-Patient Mismatch Predicts Structural Valve Degeneration in Bioprosthetic Heart Valves

Background—Prosthesis-patient mismatch (P-PtM) after aortic valve replacement results in disturbed valve performance associated with increased pressure gradients. However, it is unknown whether this can be related to future structural valve deterioration (SVD) of the bioprosthesis. Methods and Results—In 564 patients (mean age, 74 5 years) receiving an aortic valve bioprosthesis, clinical follo...